- Home
- PMN vs COCP Comparison
PMN vs COCP Comparison
Compare PMN & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- COCP
- Stock Information
- Founded
- PMN 2004
- COCP 2006
- Country
- PMN Canada
- COCP United States
- Employees
- PMN N/A
- COCP N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- PMN Health Care
- COCP Health Care
- Exchange
- PMN Nasdaq
- COCP Nasdaq
- Market Cap
- PMN 16.0M
- COCP 15.4M
- IPO Year
- PMN N/A
- COCP N/A
- Fundamental
- Price
- PMN $0.99
- COCP $1.60
- Analyst Decision
- PMN Strong Buy
- COCP Strong Buy
- Analyst Count
- PMN 3
- COCP 1
- Target Price
- PMN $4.33
- COCP $6.00
- AVG Volume (30 Days)
- PMN 21.0M
- COCP 26.3K
- Earning Date
- PMN 08-07-2025
- COCP 08-13-2025
- Dividend Yield
- PMN N/A
- COCP N/A
- EPS Growth
- PMN N/A
- COCP N/A
- EPS
- PMN N/A
- COCP N/A
- Revenue
- PMN N/A
- COCP N/A
- Revenue This Year
- PMN N/A
- COCP N/A
- Revenue Next Year
- PMN N/A
- COCP N/A
- P/E Ratio
- PMN N/A
- COCP N/A
- Revenue Growth
- PMN N/A
- COCP N/A
- 52 Week Low
- PMN $0.38
- COCP $1.12
- 52 Week High
- PMN $2.05
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- PMN 67.59
- COCP 49.83
- Support Level
- PMN $0.77
- COCP $1.59
- Resistance Level
- PMN $1.59
- COCP $1.68
- Average True Range (ATR)
- PMN 0.19
- COCP 0.12
- MACD
- PMN 0.06
- COCP -0.01
- Stochastic Oscillator
- PMN 50.12
- COCP 28.57
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).